Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ReShape Lifesciences Inc (NASDAQ:RSLS)

1.57
Delayed Data
As of 3:53pm ET
 -0.0253 / -1.59%
Today’s Change
1.23
Today|||52-Week Range
10.17
+6.08%
Year-to-Date
No recent news for ReShape Lifesciences Inc.

Today’s Trading

Previous close1.60
Today’s open1.60
Day’s range1.56 - 1.60
Volume114,885
Average volume (3 months)799,362
Market cap$47.8M
Data as of 3:53pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+87.44%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+169.40%
P/E ratio0.1
Price/Sales1.58
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
AEMDAethlon Medical Inc-0.02-1.79%
CYTXCytori Therapeutics ...-0.02-4.48%
RVPRetractable Technolo...+0.01+1.71%
--Suda Pharmaceuticals...0.000.00%
Data as of 3:59pm ET, 01/19/2018

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$786.7K
Annual profit (last year)-$23.4M
Net profit margin-2,969.62%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Dan W. Gladney
Senior VP-Operations &
Business Development
Peter M. Delange
Corporate headquarters
St. Paul, Minnesota

Forecasts